Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys
about
Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPADyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeysThe modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan AfricaDopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate.Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease.Long term motor complications of levodopa: clinical features, mechanisms, and management strategies.Clinical aspects and management of levodopa-induced dyskinesia.Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells.Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.The use of nonhuman primate models to understand processes in Parkinson's disease.Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients.Levodopa-induced Dyskinesia: Clinical Features, Pathophysiology, and Medical Management.Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.The neuroregulatory properties of L-DOPA. A review of the evidence and potential role in the treatment of Parkinson's disease.Metabotropic glutamate receptors for Parkinson's disease therapy.Understanding and prevention of "therapy-" induced dyskinesias.Levodopa-induced ocular dyskinesias in Parkinson's disease.Levodopa induces dyskinesias in normal squirrel monkeys.Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.
P2860
Q28376621-6678B3A7-ED01-484E-929D-E66171B83D12Q30498440-4CEAEED3-5435-43C0-8440-F7252526C50CQ30586911-CB6A0122-D033-4F80-B248-646FBBC249F5Q32061819-BE47AA7C-3A97-4404-8430-A14FC702C583Q34214529-7F131054-F4EA-4258-871C-36826A1BBD04Q35474975-6A13D2C1-F162-40AA-A760-1FE9B7113EBDQ35858048-6430192D-3CF1-4882-9B03-6DD7A4A17B29Q36022700-05F0BF3A-418D-4726-8052-462991D0A37EQ37101777-42414FBE-C265-476B-944E-75EEBDFFE4F3Q37924629-F13AD349-8B22-4195-B9C2-30874E2AB7F4Q38262418-A8D1609B-858A-457C-8764-16B904DB5BAEQ39208290-1C7B4863-65DE-4693-B1D7-D3668307B77EQ41566638-AAFE50A3-6BFC-4BEE-A580-F1B5C7EC48C6Q41626118-8C4BB53D-E8D7-49DD-A591-5787B2A652C3Q41738298-DAC10E1A-BF27-4EBA-8638-E233E4C98111Q41741243-0093AB71-29C1-4570-AFC8-9C775EF04812Q41818450-C11CC4F9-72C1-443A-A268-346379FDB717Q42052125-FB80D157-8FE1-40C7-A3F5-0E513DEA014BQ42164140-33AE1EC3-89C0-4ED4-B7A2-7C5B5976DDE2Q43708064-9B414173-5D46-4013-8118-188C1CFB77B3Q44165230-452F7F98-95AF-45A8-A50E-D643C8C9EC64Q50093660-55181748-99C0-4483-BBE9-DB232A5B18A4Q53509756-B7A4D3D9-0652-4C9F-8957-E15E1344BBAE
P2860
Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@ast
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@en
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@nl
type
label
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@ast
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@en
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@nl
prefLabel
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@ast
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@en
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@nl
P2093
P1476
Nigrostriatal damage is requir ...... by L-DOPA in squirrel monkeys
@en
P2093
M J Steventon
N M Rupniak
S D Iversen
P304
P356
10.1097/00002826-199010000-00006
P407
P577
1990-10-01T00:00:00Z